Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon


Updated safety and performance data for the SWING trial 24-month data will be...

Related Keywords

Minnesota ,United States ,Australia ,New Zealand ,Sydney ,New South Wales ,New York ,Eden Prairie ,Ramon Varcoe ,Nasdaq ,Surmodics Inc ,International Symposium On Endovascular Therapy ,Professor Ramon Varcoe ,Sirolimus Drug Coated Balloon ,Year Results With The Sundance ,From The ,New York Hilton Midtown ,Grand Ballroom East ,Wales Hospital ,Operating Theatres ,South East Sydney Health ,Annual International Symposium ,Endovascular Therapy ,Rutherford Clinical Classification ,Sundance Sirolimus Drug Coated Balloon ,Annual Report ,Markets ,